Gilead Raday
Biomedical Sciences
Redhill Biopharma
Israel
Biography
Gilead Raday previously served as interim CEO of Sepal Pharma, and as a director at TK Signal and Morria Biopharmaceuticals. He is a graduate of the University of Cambridge (M.Sc. in Bioscience Enterprise) and the Hebrew University of Jerusalem (M.Sc. Neurobiology, BSc Mathematics, and Biology).
Research Interest
Biomedical Sciences
